Pneumocephalus during cabergoline treatment of an invasive macroprolactinoma.
Jouret
F
F
Division of Endocrinology, Clinique Saint-Pierre, Ottignies, Belgium.
Col
V
V
D000328:Adult; D000077465:Cabergoline; D018491:Dopamine Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D004873:Ergolines / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010911:Pituitary Neoplasms / Q000188:drug therapy*; D011007:Pneumocephalus / Q000139:chemically induced*; D015175:Prolactinoma / Q000188:drug therapy*
D018491:Dopamine Agonists; D004873:Ergolines; D000077465:Cabergoline